EHU060641
MISSION® esiRNA
targeting human BAG5
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GCTCGGAATTAAAGGCTTCCTCTGGGTGCCTGCTGAACAACTGAGCTCATGTCATGGGCATGTGGTGGTTTCTCTGTTGCCTGAAAGAGCCATTAAAGTCAGTCGTGCGTGAAGCATCTCTCTTCTAAAGGATGTGTATTTCCATAAATGCTTTCTGAGGATCCGGTACAAAATGATTTCCCAAAGTTCTGAAGTGCCTTGAGAACATGTGGGTCCGAGTGTTATAACAGACTCCTCCCCCGGGTCACCTTTTGCCTGGTCATCCTGTTAGAGTACATCTTTGGAAATCCAGGGTAATATTCTCTTTCAGAGATGCTCATTGTGTAACTCTGTGTAGGGAGATAGTCACTTTAAACAGCTCAAAGTAGCTAGCTAAAGGAGTAGCCTTAAATACCTAAAAGATGACAGAAGCATAGCCC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... BAG5(9529)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Subramanyam Dasari et al.
Molecular cancer research : MCR, 18(8), 1202-1217 (2020-05-01)
Treatment of ovarian cancer is limited by extensive metastasis and yet it remains poorly understood. We have studied the critical step of metastatic colonization in the context of the productive interactions with the metastatic microenvironment with a goal of identifying
Xuetian Yue et al.
Cell discovery, 2, 16039-16039 (2016-11-04)
Tumor suppressor p53 is the most frequently mutated gene in human tumors. Many tumor-associated mutant p53 (mutp53) proteins gain new tumor-promoting activities, including increased proliferation, metastasis and chemoresistance of tumor cells, which are defined as gain-of-functions (GOFs). Mutp53 proteins often
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU060641-50UG | 04061828327126 |
| EHU060641-20UG | 04061828562794 |